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Regulation  of the  immune  system  has  been  shown  (1)  to  result  from  complex 
interactions among subsets of lymphocytes and other cells. Some of these interactions 
are defined as genetically restricted  when the effective interaction  requires  a  certain 
identity among the cells involved. The genetic restrictions reflect the specificity of the 
T  lymphocyte's receptors and are of two types:  (a)  As originally proposed by Jerne, 
idiotype specificities  determined  by Igh-linked genes direct  interactions  among lym- 
phocyte clones, including T  lymphocytes. (b) The other set of restrictions concerns the 
antigens of the major histocompatibility complex (MHC), 1 H-2 in the mouse. Ly-1 + 
helper  and  delayed-type  hypersensitivity  T  cells  (DTH)  are  restricted  to  react  to 
antigen together with gene products of the I-A or I-A-I-E subregions of the murine H- 
2  complex,  whereas  cytolytic  T  cells  are  committed  to  interact  with  K  and  D 
specificities.  In this study, we analyzed the genetic  restrictions  controlling the inter- 
actions of suppressor T  cell subsets. 
Suppressor cell circuits in the regulation of T  cell dependent antigen-specific DTH 
have been well studied in several murine systems (2-7). In the sequence of activation 
of the  three  major  subsets  of suppressor  T  cells  (Tsl,  Ts2,  Ts3),  the  interaction 
between second-order suppressor cells (Ts2) and third-order suppressor cells (Ts3) has 
been shown to be restricted by genes that map to the XIIth (Igh- 1 linked) and XVIIth 
(H-2  MHC)  chromosomes  (3,  6)  of the  mouse.  The  structural  elements  for Igh-1- 
linked restriction  appear to be clonally expressed,  idiotypic determinants  present  on 
the antigen-binding cell surface receptors of first-order suppressor cells (Tsl)  and also 
identifiable  on soluble  suppressor  factor produced  by Tsl  (TsF1)  (5).  The  same  or 
similar idiotype determinants  are present on the cell surface receptors of the Ts3 cell 
(7). It has been shown that Tsl  or TsF1 stimulates  a  population of anti-idiotypic Ts2 
cells  capable  of producing and  secreting TsF2.  TsF2  binds  to and  triggers Ts3  cells 
that express the same kind of idiotypic determinants  that  are on the TsF1 molecule. 
This idiotypy, therefore,  appears  to govern certain  aspects of Ts subset  interactions. 
On the other hand,  although many suppressor T  cells express I-J determinants,  and 
I-J restrictions have been reported, little is known about how such a restriction occurs 
* Supported by grants AI-16393-03  from the National Institutes of Health, Bethesda, MD. 
~: To whom all correspondence should be addressed. 
1 Abbreviations used in this paper:  ABA,  azobenzenearsonate; ABA-SC, ABA-coupled spleen cells; APC, 
antigen-presenting cells; CTL, cytotoxic T lymphocytes; DTH, delayed-type hypersensitivity; MHC, major 
histocompatibility complex; Tsl, Ts2, Ts3, first-, second-, and third-order suppressor T cells; TsFl, TsF2, 
first- and second-order T cell suppressor factors. 
J. ExP. MED. © The Rockefeller University Press • 0022-1007/82/11/1325/10 $1.00  1325 
Volume 156  November 1982  1325-1334 1326  I-J-RELATED ANTIGEN PRESENTATION  FOR  SUPPRESSION 
(5-7) in suppressor T  cell interactions. Although TsF1 and TsF2 are known to express 
H-2-encoded determinants (4-6), it  is not clear whether these structures function as 
restriction elements. It  is also uncertain whether I-J products present on the Tsl  or 
Ts2 cells play any special role in immune regulation. 
In  this  report,  we  present  evidence  that  (a)  the  I-J-coded  determinants on  the 
immunizing cells restrict the specificity of Ts3 cells induced in the course of immu- 
nization with azobenzenearsonate (ABA)-conjugated spleen cells, and  (b)  there  is  a 
requirement  for  identity  between  the  I-J  type  of  the  strains  where  the  Ts2  are 
generated and the I-J type of cells required for activating the Ts3 cells for suppression 
to be effective. 
The significance of these findings will be discussed in terms of the potential role of 
the I-J subregion gene product in suppressor cell generation. We suggest that I-J gene 
products  may  provide  an  analogous  function  to  the  I-A,  I-A-I-E subregion  gene 
product required for antigen presentation in positive immune responses (9-11). 
Materials and Methods 
Mice.  A/J (H-2", Igh-le), A.BY  (H-2  b, Igh-U), C57BL/6(H-2  b, Igh-lb), B10.A(5R)  (H-2 ~5, 
Igh- lb), and (A.By ×  A/J)F1 (H-2 a/h, Igh-1 ~) B 10.Br (H-2  k, Igh-1 h) B 10.D2 (H-2  a, igh-1 b) mice 
were  oblained from  The Jackson  Laboratory,  Bar  Harbor,  ME.  B10.A(3R)  (H-2  ia,  Igh-1 h) 
B 10.A(4R) (Igh- lb), and B 10.A(5R) were also obtained from Dr. Martin Doff, Harvard Medical 
School,  Boston,  MA,  and  were  maintained in  our  animal  facility  at  the  Department  of 
Pathology, Harvard Medical School. All strains of mice were used at 8-12 wk of age. 
Antigen Presentation and Immunization.  Erythrocyte-free spleen cells were conjugated with ABA 
by incubating with actiwued ABA diazonium salt solution at a final concentration of 10 raM, 
as described previously (9). For immunization, 3 ×  107 ABA-coupled spleen cells  (ABA-SC) 
were injected subcutaneously into two separate sites on the dorsal flanks of the mice. 
Assay jbr  DTH  and  C)'totoxic T  Lympho(ytes  (CTL).  5  d  after  inmmnization, mice  were 
challenged by injecting 30 ~1 of 10 mM ABA-diazonium  salt solution into the left hind footpad. 
The footpad swelling was  measured 24 h  later (9). For CTL assay,  spleens were  aseptically 
removed from mice 6-7 d after immunization. Spleen cells were  restimulated in vitro for 5 d 
with irradiated ABA-SC.  Culture condition was  7 ×  106 responder lymphocytes and 6 X  10  ~ 
stimulator cells in 1 ml RPMI  1640 plus 5% fetal  calf serum (FCS),  5 ×  10  s M  2-mercapto- 
ethanol in each well of Costar 24-well tissue culture trays. The cells were kept in a humidified, 
5% CO~ atmosphere. Cytolytic activity against ABA-coupled YAC-1 (H-2 a) or EL-4(H-2  b) target 
cells was measured by 4 h '51Cr  release assay  (10). 
Suppressor Factors.  Either TsFI extracted from spleen cells of A/J mice that had been injected 
with  5  ×  10 7  ABA-SC  7  d  earlier  (4)  or  monoclonal suppressor  factor  produced  by  Tsl 
hybridoma of A/J origin, F12  (9), was used to induce TsF2. A total of 108 cell equivalents of 
conventional first-order T cell suppressor factor (TsF  0 or 1 ml of F12 culture supernatant was 
injected intravenously into various strains of mice dailv for  5 d.  2 d  after final injection, a 
spleen cell suspension at 5 x  l0  s cells/ml in Hanks' balanced salt solution was prepared and 
underwent five cycles of freezing and thawing. Supernatant was  collected after spinning at 
12,000 rpm for 90 rain and stored at -20°C up to 2 too. TsF2, thus prepared, are designated by 
the strain of mice that were injected with TsF1 of A/J origin and when the Ts2 were generated. 
For example, TsFz-A.By indicates that the Ts2 cells used to prepare TsF2 were induced in A.By 
mice. A total of 6 ×  107 cell equivalents of TsF~ was  injected intravenously on days 4 and 5 
after immunization. Because  TsF~ requires its administration at the time of immunization to 
express  suppressive  activity,  this  protocol  enables  us  to  exclude  the  carry-over  effect  of 
transferred TsFI. 
Results 
I  Region-disparate  ABA-coupled  Cells Cannot  Prime Mice to Be Suppressed by  TsFz  We 
have previously shown that TsF2, obtained from mice given TsF1, mediates suppression TAKAOKI ET  AL.  1327 
by  triggering  an  idiotype-bearing  antigen-primed  T  cell  present  in  the  immune 
population. This cell is the Ts3 cell. To determine whether the activation of Ts3 cells, 
after  immunization  with  ABA-coupled  cells  is  restricted,  B10.A,  B10.Br,  and 
B 10.A(4R) cells were coupled with ABA and used to prime A/J mice. Previous studies 
(9)  had  indicated  the  effectiveness  of  H-2-congenic  hapten-coupled  cells  in  ABA 
priming;  in  those  studies,  I-A region  identity was  found  to  be  necessary  for  ABA- 
specific T  cell sensitization. As shown  in Table I, immunization with  ABA-coupled 
B 10.A or B 10.Br causes the activation of TDH cells and Ts3 suppressor cells that could, 
upon interaction with A/J TsF2, result in significant suppression of ABA-specific TDH 
activity. B10.A(4R)-coupled cells, although  capable of stimulating TDn  cells, could 
not induce Ts3  cells capable of suppressing ABA DTH  when A/J TsF2 was simulta- 
neously administered. Because B 10.A(4R) differ in the IB-D regions and B 10.Br differ 
in IC-D from A/J, we conclude from this experiment that I  region gene products in 
the  I-B,  I-J, or  IE  regions  must  match  between  the  immunizing  inoculum  for Ts3 
sensitization and the TsF2 for effective suppression. 
Selective  Suppression  by Parental TsFz in F1 Mice Primed with either Parental Cells Coupled 
with  ABA.  We  then  evaluated  the  activation  and  triggering signals  in  two  ways, 
namely,  using  matching  of  the  priming  cells  and  the  recipient,  and  second,  by 
evaluating  the  H-2-restricted  interaction  of TsFz  with  the  priming  cells in  greater 
detail. 
Because Ts3  is activated during the course of immunization, attempts were made 
to further document the requirement for restricted antigen presentation in the effective 
generation  of Ts3  and  to  evaluate  any  special  relationship  between  TsF2  and  the 
immunizing cells.  (A.By ×  A/J)F1  mice were  immunized  with  either ABA-coupled 
A/J cells or ABA-coupled A.By cells and injected with either TsF2-A/J or TsF2-A.By, 
and the subsequent ABA-specific DTH  and CTL responses were assayed. 
As shown  in  Figs.  1 and  2,  suppression was selectively limited to the H-2  type of 
ligand-coupled cells used for priming of Ts3.  Effective suppression was only observed 
when  ABA-coupled cells and  TsF2  had  the same  genetic origin.  This  suggests  that 
the Ts3  cells are selected by antigen  and  some  H-2  determinants  expressed on  the 
antigen-coupled  cells  to  be  prepared  for  triggering  by  TsF2.  Furthermore,  when 
(A.By ×  A/J)F1 animals were immunized with ABA coupled to (A.By ×  A/J)F1 cells, 
the ABA-specific DTH  and CTL  responses were equally suppressed by either TsFz- 
TABLE  I 
I Region-disparate ABA-coupled Cells Cannot Prime Mice to Be Suppressed by TSF2 
H-2 formula  Footpad swelling  Immunization*  Treatment:~  K ABJEC SD  ×  10  -2 mm 
ABA-B10.BR  k  kkkkk  kk  --  21.25 + 3.3 
ABA-B10.BR  k  kkkkk  kk  TsF2  5.7 +  1.6 (P< 0.01) 
ABA-B10.A  k  kkkkd  dd  --  26.5 +  1.4 
ABA-B10.A  k  kkkkd  dd  TsF2  10.5 +  1.8 (P < 0.01) 
ABA-B10.A (4R)  k  kbbbb  bb  24.25 _  2.6 
ABA-BI0.A (4R)  k  kbbbb  bb  TsF2  19.25 _  2.8 (NS)§ 
* Groups of A/J mice were immunized  with  3 ×  10  7 ABA-conjugated B10.BR or 
BI0.A or B10.A (4R) spleen cells. 
:~ 5 d later, some of these mice were injected with an A/J TsF2 prepared from Ts2 
induced by A/J TsFi. (5 ×  10  7 cell equivalent)  1 d before challenge. 
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FIG.  1.  Selective  suppression of ABA-specific  DTH  in  (A.By  X  A/J)F]  mice  by  parental  TsF2. 
(A.By  ×  A/J)Fa mice were immunized subcutaneously on day 0 with either ABA-SC of A.By or 
ABA-SC or A/J. A total of 6 ×  107 cell equivalents of either TsFz-A/J (experiment  1) or TsF2-A.By 
(experiment 2)  was injected intravenously on days 4 and 5.  Challenge with 30 #1 or  10 mM ABA 











ABA-Aid  Primed 
ABA-EL4 Target 
ABA-A By  Primed 
ABA-EL4  Torgef 
ABA-A/J Primed 
ABA-YAC Target 
ABA-A By Primed 
ABA-YAC Target 
lOO 1  33  I  I00  I  33 I 
EFFECTOR/  TARGET  RAT/O 
FK;.  2.  Selective  suppression ofABA-specific CTL generation in (A.By ×  A/J)F1 mice by parental 
TsF~. (A.By  x  A/J)F, mice were immunized subcutaneously on day 0 with 3 ×  10  7 of either ABA- 
SC or A/J or ABA-SC or A.By. A total of 6 X  10 7 cell equivalents of either TsF2-A/J or TsF2-A.By 
was injected intravenously on days 4 and 5, and spleens were removed on day 7.  For 5 d,  7 x  10  6 
cells were incubated with 6 ×  10  6 ABA-coupled and irradiated spleen cells of (A.By  x  A/J)Fa in  l 
ml of medium. Cytotoxicity against ~lCr labeled-ABA-coupled YAC-1  (H-2  a) cells and EL-4(H-2  b) 
cells was determined by 4-h release  assay. Positive control  (O),  TsF2-A/J (&), and TsF2-A.By (A). 
The negative control (O) did not receive  in vivo immunization but was stimulated in vitro for 5 d 
in the same way as the other groups. 
A.By and TsF2-A/J  (data not shown). 
To  evaluate  the  role  of I-J  in  the  TsF2,  we  obtained  TsF2  from  B10.A(3R)  or 
B 10.A(5R)  mice. Suppression with TsF2-B 10.A(5R)  and TsF2-B 10(3R)  was tested by 
the same protocol. TsFz-B10.A(5R)  suppressed only the response of (A/J  x  A.By)Fa TAKAOKI  ET  AL.  1329 
TABLE  II 
I-J Restriction in Selective Suppression by TsF2 in (A.By  ×  A/J)F1 Hybrid 
Mice 
TsF2  H-2 formula 
induced in*  K ABJEC SD 
Percent suppression  for :~ 
ABA-A/J  ABA-A.By 
primed  primed 
BI0.A (3R)  b  bbbkd  dd  3.2  50.2 
B10.A (5R)  b  bbkkd  dd  56.7  12.1 
(A.By ×  A/J)F1 mice were immunized subcutaneously with 3 ×  107 ABA- 
SC of either A/J or A.By on day 0. TsF2 were injected on days 4 and 5 at a 
total dose of 6 ×  10  7 equivalents. Challenge with 30 #1 of 100 mM ABA was 
performed on day 5, and 24-h footpad swelling was assessed. 
* TsF2 were induced  in  B10.A(5R)  and  B10.A(3R)  by  5 daily  intravenous 
injections  of F12 supernatant at a total of 1 ml. 
Percent suppression  is ([positive -  TsF2 group]/[positive -  negative])  ×  100. 
TABLE  III 
Immunization with I-J-disparate ABA-coupled Cells Prevents Suppression by TsF2 
H-2 formula  TsF2  Footpad swelling  Immunization*  K ABJEC SD  treatmentS:  ×  10  -2 mm§ 
ABA BI0.A (5R)  b  bbkkd  dd  --  26 +-- 3 
ABA B10.A (5R)  b  bbkkd  dd  BI0.A (5R)  10.6 + 3.6 (P< 0.01) 
ABA B 10.A (5R)  b  bbkkd  dd  B10.A (3R)  20 +  2.3 (P <  0.25) 
ABA-B10.A (3R)  b  bbbkd  dd  --  25 -  2.3 
ABA-B10.A (3R)  b  bbbkd  dd  B10.A (3R)  10 -  2.6 (P< 0.018) 
ABA-B10.A (3R)  b  bbbkd  dd  B10.A (5R)  21 +  1.3 (P< 0.36) 
Challenge only  --  7.6 +  1.3 
* (C57B1/6 × A/J)F1 (bbbbbbbb × kkkkkddd)F1 mice were immunized subcutaneously with 
3 ×  10  7 ABA-SC of either BI0.A (5R) or B10.A (3R) on day 0. 
:~ TsF2 prepared in B10.A (3R) or BI0.A (SR) mice using F12 (see Table II) were injected on 
days 4 and 5 at a total dose of 6 ×  107 equivalents. 
§ Challenge was performed using 30 #1 of 100 mM ABA on day 5, and 24 h footpad swelling 
was assessed. 
mice primed with ABA-coupled A/J  cells, and TsF2-B 10.A(3R)  suppressed  only when 
F1 mice were immunized  with ABA-coupled A.By cells (Table  II). Thus,  I-J identity 
between the TsF2 and  the immunizing  cells is required  for suppression. 
The  results  of the  CTL  assay  (Fig.  2)  also  provide  important  information  with 
respect  to the effect of in vivo antigen priming.  The priming with ABA-coupled cells 
was absolutely specific. For example, spleen cells of (A/J ×  A.By)F1 mice primed with 
ABA-coupled  A/J  cells  only  killed  ABA-coupled  YAC-I(H-2 a)  target  cells  but  not 
EL-4(H-2 b)  target  cells.  Furthermore,  we also showed  that  ABA-specific proliferative 
responses  in  the  F1  hybrid  could  be  selectively  activated  in  a  haplotype-specific 
manner  using  the  same  protocol  as  described  here  (data  not  shown).  These  data 
strongly  suggest  that  no  representation  of antigens  occurred  for activation  of either 
CTL  effector  cells,  T  proliferative  cells,  and  Ts3  cells.  Collectively,  these  results 
indicate  that  there  is  a  necessity  for  I-J  matching  between  the  TsF2  and  the  ABA- 
coupled cells used  to induced  Ts3  for suppression  to occur. 
Mapping  of the  Inductive  and  Triggering  Signals for  Ts3 Functions.  To  establish  the  I 
region restrictions for the activation of Ts3 cells, the following experiments were done. 
(C57BL/6  ×  A/J)F1  mice were  primed  with  ABA-coupled  B10.A(3R)  or B10.A(5R) 1330  I-J-RELATED ANTIGEN  PRESENTATION  FOR  SUPPRESSION 
TABLE  IV 




Immunization*  [t-2 formula  TsF2  11 : 1  Lytic 
K ABJEC SD  treammnt~: effector-to- units ]] 
target 
ratio§ 
ABA-B10.A (3R)  b  bbbkd  dd  18  3.5 
ABA-BI0.A (5R)  b  bbkkd  dd  --  18  3.6 
ABA-BI0.A (3R)  b  bbbkd  dd  B10.A (3R)  0  0.0 
ABA-BI0.A(3R)  b  bbbkd  dd  BI0.A (5R)  13  2.5 
ABA-B10.A(SR)  b  bbkkd  dd  BI0.A (3R)  15  3.1 
ABA-BI0.A (5R)  b  bbkkd  dd  BI0.A (SR)  2  0.4 
--  --  --  1  0.2 
* Immunization as in Table III. 
~: TsF2 was prepared and used in the same manner as Table III. 
§ 7 ×  10  6  B6AFI responders were cultured  for 5 d with 6 ×  106 A.By irradiated 
stimulators in 2 ml RPMI with 1% FCS. Effectors were harvested and tested for 
ability to lyse 5~Cr-labeled  A.By Con A blast target cells in standard 4 h SlCr release 
assay. 
II  Lytic unit is defined as the number of spleen cells required to give 50%  specific 
release from 104 target cells in 4 h. 
cells. This strain combination permits us to evaluate the role of I-J, while it minimizes 
any significant allogeneic effects  and  permits  the  necessary I-A region  identity for 
ABA priming. Groups of these  mice received TsF2 induced in either B10.A(3R)  or 
B10.A(5R)  mice. The mice were evaluated for ABA-specific responses on day 5. The 
data shown in Tables III and IV demonstrate the requirement for I-J matching of the 
hapten-coupled cells used  to  prime mice for Ts3  and the TsF2 necessary to  trigger 
these cells to manifest suppression. 
Discussion 
The major finding in this report  is  the  genetic restriction of Ts3  activation and 
function, illustrated by the special relationship between the TsF2 molecule and the 
ABA-conjugated cells required to activate Ts3. To activate Ts3 cells that, in the ABA 
system, appear to be the final effector suppressor cells, two events are required. First, 
the Ts3 must be induced by appropriately presented ligand at  the time of priming, 
and,  second,  TsFz  or  a  similar signal  must  trigger  the  primed  cell.  The  Ts3  cells 
induced appear to require ligand presented by cells that are I-J identical to the TsF2 
subsequently used for complete suppression to occur. Thus, 1-J gene products may be 
critical for the induction and triggering of Ts3 cells, and this might indicate that I-J 
gene products play a  critical role as a  restriction element in the suppressor pathway. 
In the ABA system, two clusters of genes are important in the suppression. The Igh- 
1-1inked  set  of  genes  encode  idiotype-like structures  that  govern  certain  levels  of 
interaction between members of this pathway. Tsl cells induced by ligand in certain 
strains,  e.g.,  A/J,  express  idiotype-like structures  and  elaborate  idiotype  and  I-J- 
bearing molecules, termed TsF1.  This TsF1,  in  the  absence of further antigen, can 
induce anti-idiotypic Ts2 cells in any recipient strain. Ts2 cells or TsF2 derived from 
these cells must, however, interact with antigen-primed idiotype-bearing Ts3 cells for TAKAOKI ET AL.  1331 
suppression  to occur.  Furthermore,  we have also shown  that  the anti-idiotypic Ts2 
and  its idiotype target must be H-2 identical.  Specifically, this is illustrated  by our 
observation  that,  when  A/J  TsF1  is  used  to  induce  Ts2  in  A.By  (H-2  b,  Igh-1  e)  or 
C57B1/6 (H-2  b, Igh- lb), the Ts2 can be shown to be active only in A.By (H-2  b, Igh-1  b) 
and  do not  function  in A/J or C57B1/6.  C57B1/6,  although  H-2 identical  to A.By, 
does  not  express  cross-reactive  idiotype.  In  this  study,  attention  to  the  rules  of 
matching between the TsF2 and Ts3 cells at the H-2 and Igh-1 region has permitted 
us to identify the role of I-J-coded determinants in these interactions. 
To account for the requirement of I-J identity between the TsF2 and the cells used 
to induce Ts3, we propose that  the Ts3 cells, in addition  to ligand, recognize an I-J 
determinant on certain hapten-coupled cells. This I-J structure is apparently the same 
that is recognized on the anti-idiotypic I-J-bearing TsFz molecule. Thus, the Ts3 cell 
behaves as an analogue of the murine Ly-1 + T  cell subset described by Schwartz and 
Paul  (11)  and others, which recognize I-A, I-A-I-E gene products and antigen on the 
surface of specialized antigen-presenting cells. If this is the case, I-J gene products are 
restriction elements for Ts3 activation. 
This  interpretation  is  supported  by  the  results  from  the  experiments  described 
herein,  in  which  the  (C57B1/6  ×  A/J)F1  immunized  with  either  B10.A(3R)  or 
B10.A(5R) cells coupled to antigen failed to be suppressed by the TsF2 induced in the 
I-J-disparate strain. In other words, Ts3 are activated by certain I-J gene products on 
the  immunizing cells  in  addition  to the haptenic  determinant.  These determinants 
must be identical  with  I  region  gene products of the host  in which  Ts2  is induced. 
However, we have not yet obtained structural evidence that the H-2 product on the 
immunizing cell is the I-J antigen. These experiments are currently in progress using 
monoclonal anti-I-J antibodies. 
Involvement of molecules encoded by the I-J subregion in immunological suppres- 
sion  have  been  considered  for  several  years.  Indeed,  I-J  restrictions  were  initially 
reported in the elegant studies of Tada and colleagues (12).  In addition,  most of the 
Ts and their soluble mediator molecules bear I-J-coded antigens. Certain I-J region- 
encoded  antigens  have also been shown to be present  on some other nonsuppressor 
subsets of cells (13-17). Functional associations of I-J subregion and suppression were 
also recently reported for the phenomena in which  allogeneic interactions across I-J 
subregion differences results in the suppression  (18-19).  These studies indicated that 
anti-I-J-I-J interactions could trigger Ts 1 or Ts2 cells (20).  More recently, I-J-specific 
(i.e.,  anti-I-J) allogeneic effect factor has been shown to provide the activation signal 
for a certain subset of Ts (21). As presented here, the function of TsFz is also restricted 
to the I-J subregion. In this regard, similar I region restrictions have also been reported 
for suppression induced  by Ts cells in the nitrophenyl  system (22).  In other antigen 
systems,  I-C  (23)  and  I-J  (24,  25)  regions  have  all  been  shown  to  individually 
determine restrictions. 
It  is generally considered  that  antigens  must  be presented  on antigen-presenting 
(APC) cells to stimulate immune reactivity effectively. APC activity seems to require 
expression  of  I  region-associated  (Ia)  antigen  and  ligand.  In  some  experimental 
systems, spleen cells chemically coupled with haptenic determinants are also effective 
as  APC.  The evidence  for the  requirement  of Ia, or more precisely I-A subregion- 
encoded antigens in the ABA system for effective presentation has been accumulated; 
ABA-coupled spleen cells that shared I-A subregion with the responding animal were 1332  I-J-RELATED ANTIGEN PRESENTATION FOR  SUPPRESSION 
effective in the immunization for ABA-specific DTH (9),  and the immunization was 
inhibited by the administration of anti-I-A antibodies into the animal (26). Treatment 
of APC with monoclonal anti-I-A antibody and complement completely prevents in 
vitro  ABA-specific  CTL  activity  (A.  Tominaga  and  M.  I.  Greene,  manuscript  in 
preparation).  Abrogation of immunity by anti-I-A antibodies has also been recently 
shown  in  several  other  antigen  systems  (28,  29).  Moreover,  monoclonal  anti-I-A 
antibodies coupled with ABA induced  unresponsiveness rather than  inducing  DTH 
(27).  Thus,  activational  signals  associated  with  I-A molecules  are  required  for the 
induction of immunity, and the lack of these signals seems to lead to unresponsiveness 
(27-29). 
Antigen presentation for activation of Ts, on the other hand, has not been previously 
considered.  It  has  been  simply assumed  that  the  antigens  that  escaped  trapping, 
processing, and presentation by the reticuloendothelial system (RES)  directly bound 
to  and  activated  Ts.  This  is  based  on  several observations  (30)  that  the  form and 
route of administration of antigen that led to limited handling by the RES, i.e., such 
as intravenous administration  of cell-bound antigens, etc., were effective inducers of 
tolerance  and  suppression.  Such  Ts were,  however, always evaluated  in  animals or 
systems that  had  been primed with  antigen.  Because the Ts3 activation and subse- 
quent  interaction with TsF2 molecules appear to be a  major site of I-J restriction,  it 
is not surprising that I-J presentation was not formally identified in these aforemen- 
tioned studies.  Results presented in this report suggest, however, the existence of I-J- 
related antigen presentation for the activation of at least a certain subset of Ts (Ts3). 
This presentation  appears to be an analogous counterpart  of I-A- or I-A-I-E-related 
antigen  presentation  necessary  for helper or  DTH  immune responses.  However,  in 
some unexplained manner, the contribution of I-J-positive APC may also be relevant 
for certain positive immune responses (16).  Indeed I-J  + APC cells may quantitatively 
and qualitatively govern many aspects of the immune response. 
Summary 
The genetic restrictions of the activation of third-order suppressor cells (Ts3) were 
studied in mice, using two different types of anti-azobenzenearsonate (ABA)-immune 
responses, namely delayed-type hypersensitivity (DTH) and cytotoxic T  lymphocyte 
(CTL)  generation.  Ts2  cells  were  induced  in  several  different  strains  of mice  by 
injecting monoclonal T  hybridoma molecules or first-order suppressor factors (TsF1) 
originating  in A/J  (H-2  a,  Igh-1 ~)  mice and  then  testing the TsF2 molecules derived 
from these Ts2 in A/J and A.By (H-2  b, Igh-1 e) or (A/J X A.By)F1 (H-2  a/b, Igh-1 e) and 
(C57B1/6 X A/J)F1 (H-2  b/a, Igh-1 b/e) mice. It was shown that the activity of TsF2 was 
restricted  to  the  I-J of the  strain  in  which  Ts2  was  induced.  By  genetic  analysis, 
restriction  was shown  to be due  to  the  requirement  of H-2 identity  between  ABA- 
coupled cells used for Ts3 activation and the strain of the TsFz origin.  Moreover, by 
using  H-2-congenic  ABA-coupled  cells,  we  were  also  able  to  precisely  map  and 
demonstrate that ABA-coupled cells I-J identical  to TsF2 induced  in  various strains 
were  necessary  for  effective suppression  to  occur.  This  selective  activation  of Ts3 
suggested  the  existence  of I-J-related  antigen  presentation  for  suppression  as  the 
counterpart  of I-A or  I-A-I-E-restricted antigen  presentation  for  positive  immune TAKAOKI ET  AL.  1333 
responses. 
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